These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 22860749)

  • 1. Functional genomic and high-content screening for target discovery and deconvolution.
    Heynen-Genel S; Pache L; Chanda SK; Rosen J
    Expert Opin Drug Discov; 2012 Oct; 7(10):955-68. PubMed ID: 22860749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in quantitative high throughput and high content data analysis.
    Moutsatsos IK; Parker CN
    Expert Opin Drug Discov; 2016; 11(4):415-23. PubMed ID: 26924521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of Historical Bioactivity Data in the Deconvolution of Phenotypic Screens.
    Bornot A; Blackett C; Engkvist O; Murray C; Bendtsen C
    J Biomol Screen; 2014 Jun; 19(5):696-706. PubMed ID: 24441646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening methods for influenza antiviral drug discovery.
    Atkins C; Evans CW; White EL; Noah JW
    Expert Opin Drug Discov; 2012 May; 7(5):429-38. PubMed ID: 22435452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel trends in high-throughput screening.
    Mayr LM; Bojanic D
    Curr Opin Pharmacol; 2009 Oct; 9(5):580-8. PubMed ID: 19775937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Image-based high-content screening in drug discovery.
    Lin S; Schorpp K; Rothenaigner I; Hadian K
    Drug Discov Today; 2020 Aug; 25(8):1348-1361. PubMed ID: 32561299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of Imaging-Based Assays in Microplate Formats for High-Content Screening.
    Fogel AI; Martin SE; Hasson SA
    Methods Mol Biol; 2016; 1439():273-304. PubMed ID: 27317002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in high-throughput flow cytometry for drug discovery.
    Ding M; Baker D
    Expert Opin Drug Discov; 2021 Mar; 16(3):303-317. PubMed ID: 33054417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel methods and approaches to acute lymphoblastic leukemia drug discovery.
    Wei MC; Cleary ML
    Expert Opin Drug Discov; 2014 Dec; 9(12):1435-46. PubMed ID: 25212992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The development of high-content screening (HCS) technology and its importance to drug discovery.
    Fraietta I; Gasparri F
    Expert Opin Drug Discov; 2016; 11(5):501-14. PubMed ID: 26971542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel drug discovery for Chagas disease.
    Moraes CB; Franco CH
    Expert Opin Drug Discov; 2016; 11(5):447-55. PubMed ID: 26967915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The complete automation of cell culture: improvements for high-throughput and high-content screening.
    Jain S; Sondervan D; Rizzu P; Bochdanovits Z; Caminada D; Heutink P
    J Biomol Screen; 2011 Sep; 16(8):932-9. PubMed ID: 21775700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-throughput fluorescence imaging approaches for drug discovery using in vitro and in vivo three-dimensional models.
    Martinez NJ; Titus SA; Wagner AK; Simeonov A
    Expert Opin Drug Discov; 2015 Dec; 10(12):1347-61. PubMed ID: 26394277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional Genomics in Pharmaceutical Drug Discovery.
    Adams R; Steckel M; Nicke B
    Handb Exp Pharmacol; 2016; 232():25-41. PubMed ID: 26330261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of Plant Productivity in the Post-Genomics Era.
    Thao NP; Tran LS
    Curr Genomics; 2016 Aug; 17(4):295-6. PubMed ID: 27499678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemical genomics and emerging DNA technologies in the identification of drug mechanisms and drug targets.
    Olsen LC; Færgeman NJ
    Curr Top Med Chem; 2012; 12(12):1331-45. PubMed ID: 22690680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Yeast: bridging the gap between phenotypic and biochemical assays for high-throughput screening.
    Denny PW
    Expert Opin Drug Discov; 2018 Dec; 13(12):1153-1160. PubMed ID: 30326751
    [No Abstract]   [Full Text] [Related]  

  • 18. Using iterative cluster merging with improved gap statistics to perform online phenotype discovery in the context of high-throughput RNAi screens.
    Yin Z; Zhou X; Bakal C; Li F; Sun Y; Perrimon N; Wong ST
    BMC Bioinformatics; 2008 Jun; 9():264. PubMed ID: 18534020
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.